Clinician (Oncology / Hematology)

What you would do

• Review Clinical Study Reports, safety updates, protocols, and regulatory correspondence to assess clinical validity and internal consistency
• Use CTCAE and specific response standards (RECIST, Lugano, IMWG, IWCLL, ELN) to assess whether reported toxicity grades and efficacy determinations are valid
• Assess benefit-risk conclusions by checking whether claimed benefits are supported by the data and realistic for the patient population
• Flag clinically implausible narratives or unexplained contradictions between patient data and reported outcomes
• Write clear, structured explanations of your clinical judgments so non-specialists can understand and verify your reasoning

Who they want

• Board certification or specialist registration in medical oncology or hematology with minimum 5 years post-training clinical experience
• Trial roles as investigator, monitor, safety specialist, or development physician, with hands-on knowledge of CSRs, protocols, and DSMB materials
• Demonstrated proficiency with CTCAE grading and response criteria relevant to your subspecialty area
• Excellent written communication skills, with ability to explain complex clinical concepts to non-clinical audiences
• Prior medical monitoring or medical director experience in oncology or hematology programs, ideally with committee participation

Main skills

What the interview asks about

1. 1.Adverse event attribution

   You must distinguish true drug-related events from coincidental ones and justify your causality assessment with clinical reasoning that an AI system can learn from and apply to new cases.

   For example: “A 72-year-old with known coronary disease has a Grade 3 MI six weeks into treatment. What information would you need to determine if it's drug-related, and what causality would you assign?”

2. 2.Endpoint validity assessment

   You evaluate whether reported efficacy numbers actually represent clinically meaningful benefit and whether the response criteria were correctly applied, catching AI that might accept implausible claims.

   For example: “A Phase 2 trial reports 52% response using a novel definition, but standard Lugano criteria would show 38%. How do you assess whether this modification was justified?”

3. 3.Dose-limiting toxicity determination

   Your judgment on whether a dose level is truly tolerable or has crossed into unacceptable toxicity is clinical expertise that guiding AI systems need to recognize.

   For example: “At dose level 2, two patients had Grade 2 hepatotoxicity and one had Grade 1 lymphopenia; treatment expanded. Given your specialty, assess this dose-escalation decision.”

4. 4.Benefit-risk coherence

   You check whether the sponsor's claimed benefit-risk conclusion actually follows from the data, catching contradictions or unsupported optimism that AI should learn to question.

   For example: “A drug shows 60% ORR but has 35% Grade 3-4 infections and 8% treatment mortality in relapsed-refractory patients. Is this a defensible benefit-risk conclusion?”

5. 5.Document inconsistency detection

   Spotting when a CSR, protocol, or investigator brochure contains internal contradictions or unexplained changes requires deep familiarity with how clinical trials are documented and interpreted.

   For example: “The protocol specifies stopping a trial if platelet counts fall below 50K, yet the CSR describes two patients who continued treatment at 25K with no explanation. How would you investigate this discrepancy and what would you document for the AI evaluation?”

6. 6.Regulatory document reasoning

   You understand how regulators interpret clinical data and safety narratives, allowing you to identify weak arguments or missing context that an AI system should recognize as problematic.

   For example: “A post-marketing plan monitors hepatotoxicity at weeks 4, 8, 12, then every 12 weeks. Based on your specialty, are there gaps in this monitoring approach?”

A task you may get

Review a one-page case narrative from a clinical trial describing a serious adverse event and write a structured evaluation of whether the causality assessment is justified and whether the outcome should have prompted protocol changes or dose adjustments.

How to prepare

• Bring a clinical trial publication annotated with judgment calls and how you'd test AI reasoning about those decisions
• Prepare an example where standard grading criteria needed careful interpretation in your practice
• Review FDA or EMA guidance on safety grading or efficacy assessment for your subspecialty
• Collect 2-3 benefit-risk tradeoff examples you've evaluated in your medical monitoring work

The facts

Pay

$160–200/hr

Open to

Bangladesh, Hong Kong, India, Indonesia, Japan, Kazakhstan, Kyrgyzstan, Malaysia, Pakistan, Philippines, Singapore, Sri Lanka, Taiwan, Thailand, Uzbekistan, Vietnam, Austria, Belarus, Belgium, Denmark, France, Germany, Greece, Italy, Netherlands, Portugal, Russia, Spain, Switzerland, United Kingdom, Argentina, Brazil, Chile, Colombia, Mexico, Peru, Algeria, Bahrain, Egypt, Iraq, Jordan, Kuwait, Lebanon, Libya, Morocco, Oman, Palestine, Qatar, Saudi Arabia, Tunisia, United Arab Emirates, United States, Canada, Nigeria, Kenya, South Africa, Ghana, Ethiopia

Field

Medicine

Role type

Expert

Posted

8/4/2026

Places left

30

We wrote this page from the public micro1 listing. It may be out of date, so read the full posting before you apply.